产品信息
| 产品号 | 商品名 | 活性成分 | 剂型/给药途径 | 规格/剂量 | 参比药物(RLD) | 生物等效参考标准(RS) | 治疗等效代码 | 该申请号批准日期 | 该产品号批准日期 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|
| 001 | ERZOFRI | PALIPERIDONE PALMITATE | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 39MG/0.25ML (39MG/0.25ML) | Yes | Yes | None | 2024/07/26 | 2024/07/26 | Prescription |
| 002 | ERZOFRI | PALIPERIDONE PALMITATE | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 78MG/0.5ML (78MG/0.5ML) | Yes | Yes | None | 2024/07/26 | Prescription | |
| 003 | ERZOFRI | PALIPERIDONE PALMITATE | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 117MG/0.75ML (117MG/0.75ML) | Yes | Yes | None | 2024/07/26 | Prescription | |
| 004 | ERZOFRI | PALIPERIDONE PALMITATE | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 156MG/ML (156MG/ML) | Yes | Yes | None | 2024/07/26 | Prescription | |
| 005 | ERZOFRI | PALIPERIDONE PALMITATE | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 234MG/1.5ML (156MG/ML) | Yes | Yes | None | 2024/07/26 | Prescription | |
| 006 | ERZOFRI | PALIPERIDONE PALMITATE | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 351MG/2.25ML (156MG/ML) | Yes | Yes | None | 2024/07/26 | Prescription |
